BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
+64.6%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$1.62B
AUM Growth
+$1.62B
(+51%)
Cap. Flow
+$243M
Cap. Flow
% of AUM
14.99%
Top 10 Holdings %
Top 10 Hldgs %
48.03%
Holding
65
New
8
Increased
19
Reduced
26
Closed
8
Top Buys
| 1 |
argenx
ARGX
|
$82.2M |
| 2 |
Repare Therapeutics
RPTX
|
$60.3M |
| 3 |
Arcus Biosciences
RCUS
|
$45.6M |
| 4 |
Celldex Therapeutics
CLDX
|
$35.6M |
| 5 |
Protagonist Therapeutics
PTGX
|
$29.6M |
Top Sells
| 1 |
Cytokinetics
CYTK
|
$46.4M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$30.8M |
| 3 |
SWTX
SpringWorks Therapeutics
SWTX
|
$20.2M |
| 4 |
Revolution Medicines
RVMD
|
$18.9M |
| 5 |
Mersana Therapeutics
MRSN
|
$13.8M |
Sector Composition
| 1 | Healthcare | 97.45% |
